AMED
Amedisys
AMED
AMED
Delisted
AMED was delisted on the 14th of August, 2025.
326 hedge funds and large institutions have $5.19B invested in Amedisys in 2022 Q1 according to their latest regulatory filings, with 64 funds opening new positions, 127 increasing their positions, 91 reducing their positions, and 56 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
3.11% more ownership
Funds ownership: 89.75% → 92.86% (+3.1%)
1% more funds holding
Funds holding: 322 → 326 (+4)
8% more call options, than puts
Call options by funds: $57.2M | Put options by funds: $52.8M
Holders
326
Holding in Top 10
2
Calls
$57.2M
Puts
$52.8M
Top Buyers
| 1 | +$66.6M | |
| 2 | +$52.4M | |
| 3 | +$38.2M | |
| 4 |
Millennium Management
New York
|
+$36.9M |
| 5 |
FCM
Frontier Capital Management
Boston,
Massachusetts
|
+$29.1M |
Top Sellers
| 1 | -$63.3M | |
| 2 | -$56.5M | |
| 3 | -$38.2M | |
| 4 |
Ameriprise
Minneapolis,
Minnesota
|
-$35.1M |
| 5 |
CG
Carmignac Gestion
Paris,
France
|
-$25.1M |